53 / 76
HIPERTENSIÓN / 2017 / VOL. 22
53
Bibliografía
1. E. Roessler, E. Sánchez, l. Villarroel et al. “Bloqueo beta y alfa adrenergico con carvedilol en el tratamiento de hipertensos esenciales no complicados”.
Rev Chil Cardol 2004; 23: 343-352.
2. Kaplan N. “Hipertensión Clinica” 11ª Edición, pg. 215 - 219 Wolters Kluwer, Philadelphia, USA. 2015.
3. Mann Samuel J. “Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient “ J Am Soc Hypertension 2017:
11(1): 54–65.
4. B. J. Materson, D. J. Reda, W. C. Cushman et al “Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with
Placebo” N Engl J Med 1993; 328:914-921.
5. Moser M, Hebert PR. “Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials” J
Am Coll Cardiol. 1996;27(5):1214-8.
6. Bradley HA, Wiysonge CS, Volmink JA, et al. “How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic
review and meta-analysis. J Hypertens 2006; 24:2131–2141.
7. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet
2005; 366:1545–1553.
8. Turnbull F. Y Cutler J. A “ The blood Pressure Lowering Treatment Trialist´Colaboration (BPLTTC) en Hypertension “, S Oparil & M.A. Weber (edit) pg
340, Second Edition 2005, Elsevier and Saunders, Philadelphia USA.
9. Khan N, McAlister FA. Re-examining the efficacy of b-blockers for the treatment of hypertension: a meta-analysis [erratum in 2007;176:976]. CMAJ
2006;174:1737-42.
10. Dahlöf B, Sever PS, Poulter et al, ASCOT Investigators. “ Prevention ofcardiovascular events with an antihypertensive regimen of amlodipine adding
perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering
Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366:895–906.
11. Mancia G, Laurent S, Agabiti-Roseic E et al “Reappraisal of European guidelines on hipertensión management: a European Society of Hypertension
Task Force document” Blood Press. 2009;18(6):308-47.
12. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369:201–207.
13. Ministerio de Salud. “Guía clínica Hipertensión Arterial Primaria o Esencial en Personas de 15 años y más. Santiago: Minsal, 2009, Gobierno de Chile.
14. Kaplan N. “Clinical Hypertension” 7 th Edition, pg. 45 – 46 y 63 – 66 William & Wilkins, Baltimore, USA. 1998.
15. Kaplan N. “Hipertensión Clinica” 11ª Edición, pg. 51-53 Wolters Kluwer, Philadelphia, USA. 2015.
16. Henrich WL, Mailloux LU “Hypertension in dialisis” Up-todate 2013
www.uptodate.com17. Larochelle P, Tobe SW e Lacourcière Y. “b-Blockers in Hypertension: Studies and Meta-analyses Over the Years” C Journal of Cardiology 2014; 30:
S16 - S22.